These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1376427)
1. Screening for chemopreventive (anticarcinogenic) compounds in rodents. Boone CW; Steele VE; Kelloff GJ Mutat Res; 1992 Jun; 267(2):251-5. PubMed ID: 1376427 [TBL] [Abstract][Full Text] [Related]
2. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. Steele VE; Moon RC; Lubet RA; Grubbs CJ; Reddy BS; Wargovich M; McCormick DL; Pereira MA; Crowell JA; Bagheri D J Cell Biochem Suppl; 1994; 20():32-54. PubMed ID: 7616752 [TBL] [Abstract][Full Text] [Related]
3. Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. Steele VE; Sharma S; Mehta R; Elmore E; Redpath L; Rudd C; Bagheri D; Sigman CC; Kelloff GJ J Cell Biochem Suppl; 1996; 26():29-53. PubMed ID: 9154167 [TBL] [Abstract][Full Text] [Related]
4. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Pereira MA; Barnes LH; Rassman VL; Kelloff GV; Steele VE Carcinogenesis; 1994 May; 15(5):1049-54. PubMed ID: 8200067 [TBL] [Abstract][Full Text] [Related]
5. Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression. Lubet RA; Steele VE; Shoemaker RH; Grubbs CJ Cancer Prev Res (Phila); 2018 Oct; 11(10):595-606. PubMed ID: 30045934 [TBL] [Abstract][Full Text] [Related]
6. New agents for cancer chemoprevention. Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet RA; Doody LA; Malone WF; Hawk ET; Sigman CC J Cell Biochem Suppl; 1996; 26():1-28. PubMed ID: 9154166 [TBL] [Abstract][Full Text] [Related]
8. Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis. Chaudhary SC; Alam MS; Siddiqui MS; Athar M Life Sci; 2009 Jul; 85(5-6):196-205. PubMed ID: 19470390 [TBL] [Abstract][Full Text] [Related]
9. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Boone CW; Kelloff GJ; Malone WE Cancer Res; 1990 Jan; 50(1):2-9. PubMed ID: 2403415 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of organotropic effects of chemopreventive agents in multiorgan carcinogenesis models. Tsuda H; Iwahori Y; Asamoto M; Baba-Toriyama H; Hori T; Kim DJ; Uehara N; Iigo M; Takasuka N; Murakoshi M; Nishino H; Kakizoe T; Araki E; Yazawa K IARC Sci Publ; 1996; (139):143-50. PubMed ID: 8923026 [TBL] [Abstract][Full Text] [Related]
11. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379 [TBL] [Abstract][Full Text] [Related]
12. Cancer chemopreventive activity of "rosin" constituents of Pinus spez. and their derivatives in two-stage mouse skin carcinogenesis test. Tanaka R; Tokuda H; Ezaki Y Phytomedicine; 2008 Nov; 15(11):985-92. PubMed ID: 18424098 [TBL] [Abstract][Full Text] [Related]
13. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment. Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531 [TBL] [Abstract][Full Text] [Related]
14. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301 [TBL] [Abstract][Full Text] [Related]
15. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950 [TBL] [Abstract][Full Text] [Related]
16. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Singh J; Kulkarni N; Kelloff G; Reddy BS Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306 [TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats. Lubet RA; Steele VE; Casebolt TL; Eto I; Kelloff GJ; Grubbs CJ Carcinogenesis; 1994 Dec; 15(12):2775-80. PubMed ID: 8001234 [TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effect of 4'-demethyl epipodophyllotoxin on DMBA/TPA-induced mouse skin carcinogenesis. Dhawan D; Balasubramanian S; Amonkar AJ; Singh N Carcinogenesis; 1999 Jun; 20(6):997-1003. PubMed ID: 10357779 [TBL] [Abstract][Full Text] [Related]
19. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Pereira MA; Grubbs CJ; Barnes LH; Li H; Olson GR; Eto I; Juliana M; Whitaker LM; Kelloff GJ; Steele VE; Lubet RA Carcinogenesis; 1996 Jun; 17(6):1305-11. PubMed ID: 8681447 [TBL] [Abstract][Full Text] [Related]
20. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Gafner S; Lee SK; Cuendet M; Barthélémy S; Vergnes L; Labidalle S; Mehta RG; Boone CW; Pezzuto JM Phytochemistry; 2004 Nov; 65(21):2849-59. PubMed ID: 15501252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]